Your Guide to Congenital Antithrombin Deficiency
At a Glance
Congenital antithrombin deficiency is a rare genetic disorder that severely increases the risk of dangerous blood clots. Patients often experience heparin resistance, meaning standard blood thinners may not work without specialized treatments like antithrombin concentrate during emergencies or surgery.
Welcome to your patient guide for Congenital Antithrombin Deficiency (also known as Antithrombin III Deficiency). Being diagnosed with a rare genetic clotting disorder is a life-changing moment, but it does not have to be an emergency. This guide is designed to translate the complex medical science behind your condition into clear, actionable steps, so you can partner effectively with your healthcare team.
This resource is broken down into five focused sections. You can read them in order or jump directly to the topic most relevant to you right now:
Understanding Congenital Antithrombin Deficiency
Learn about congenital antithrombin deficiency, a rare genetic blood clotting disorder. Understand your DVT risk, treatment, and proactive management plan.
Symptoms and Warning Signs: What to Watch For
Learn the warning signs of blood clots caused by congenital antithrombin deficiency. Understand symptoms of DVT, PE, and when to seek emergency medical care.
Biology and Diagnosis: How It Works and How It's Found
Learn how congenital antithrombin deficiency works. Understand Type I and Type II, heparin resistance, and how lab tests and genetics confirm your diagnosis.
Treatments and Management: Blood Thinners and Antithrombin Therapy
Learn about treatment options for congenital antithrombin deficiency. Understand blood thinners, DOACs, antithrombin concentrate, and long-term clot prevention.
Navigating High-Risk Situations: Surgery, Pregnancy, and Hormones
Learn how to manage congenital antithrombin deficiency during high-risk situations like pregnancy and surgery. Understand ATc infusions and LMWH monitoring.
Your Emergency Alert Summary
Because standard emergency treatments for blood clots may not work for you, consider taking a photo of this summary to keep on your phone or print for your wallet:
MEDICAL ALERT: CONGENITAL ANTITHROMBIN DEFICIENCY
- Condition: Severe inherited thrombophilia (SERPINC1 mutation). Extremely high risk for VTE/PE.
- Critical Warning: Patient is at high risk for Heparin Resistance. Standard UFH or LMWH may be ineffective without antithrombin supplementation.
- Treatment Required: In the event of acute thrombosis or major surgery, patient may require Antithrombin Concentrate (ATc) infusion to normalize antithrombin levels alongside alternative anticoagulation (e.g., Argatroban, DOACs) or specialized heparin dosing.
You are not alone in this journey. By equipping yourself with evidence-based knowledge, you are taking the most important step toward protecting your long-term health.
Common questions in this guide
What is congenital antithrombin deficiency?
What is heparin resistance and why does it matter?
How is antithrombin deficiency treated during surgery or emergencies?
Should I wear a medical alert bracelet for antithrombin deficiency?
What are the most dangerous situations for someone with antithrombin deficiency?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my local hospital's pharmacy typically stock antithrombin concentrate for emergencies?
- 2.Should I wear a medical alert bracelet or carry a specific wallet card detailing my condition?
- 3.Who is the best specialist in our area for managing pregnancies in women with severe inherited thrombophilias?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
This page is for informational purposes only and does not replace professional medical advice. Always consult your hematologist or healthcare provider about managing your specific blood clotting risks and emergency protocols.
Get notified when new evidence is published on Hereditary thrombophilia due to congenital antithrombin deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.